GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pluri Inc (XTAE:PLUR) » Definitions » Other Income (Expense)

Pluri (XTAE:PLUR) Other Income (Expense) : ₪-0.12 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Pluri Other Income (Expense)?

Pluri's other income expense for the Pluri's pretax income for the three months ended in Mar. 2025 was ₪-3.49 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₪-0.12 Mil.


Pluri Other Income (Expense) Historical Data

The historical data trend for Pluri's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pluri Other Income (Expense) Chart

Pluri Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.10 1.30 1.95 -6.62 0.97

Pluri Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.29 -3.34 6.41 -3.49

Pluri Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pluri  (XTAE:PLUR) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Pluri Business Description

Traded in Other Exchanges
Address
MATAM Advanced Technology Park, Building No.5, Haifa, ISR, 3508409
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

Pluri Headlines

From GuruFocus

Pluri to Present and Participate in Upcoming Conferences

By Value_Insider Value_Insider 10-31-2022